 |
PSBA Adds Bioscience as Industry Focus |
| In April the PSBA expanded its industry clusters to include biotechnology. The change will facilitate support for two resident companies led by PSU faculty members, and allows a strategic partnership with the Oregon Bioscience Association (OBA).
The OBA will work with the PSBA to better understand the technology cluster and help link resident companies to resources. OBA moved its office to the PSBA in April.
The newest biotech company accepted for residence is DesignMedix, co-founded by Professor David Peyton of PSU and two partners, Lynn Stevenson and Sandra Shotwell. The company's intellectual property is based on work that Peyton did within University labs and is considered University IP. The company will move in during May.
The first PSU faculty-led company to locate at the PSBA was Portland Bioscience in 2006. It is headed by Professor Steve Benight. The two companies have business offices as well as lab spaces at the PSBA.
Other industry clusters at the PSBA include Information Technology/Software and Green Tech/Sustainability. These three sectors, including Biotechnology, now account for 85% of the 21 companies in residence. |
|
Florida-based WeoGeo Relocates to Portland |
|
WeoGeo is building a web marketplace for mapping the world. And this spring it decided it wanted to do that from Portland, Oregon. The Florida company began moving its operations to the PSBA in February.  It plans to complete the move by June. The company's product allows scientific and technical users to conveniently store, search, sell and exchange high-resolution CAD and GIS mapping products. Read more about WeoGeo. |
|
PSBA Companies Report Banner-Year Growth |
| Resident companies at the PSBA reported a 35% increase in employee numbers for 2007 over 2006 results. This was the highest reported employment growth yet for PSBA companies. Growth for 2006 was 29% over 2005.
Of the ten companies that were at the PSBA during all of 2006 and 2007, all reported solid revenue growth, as well as success for many in either raising investment dollars or gaining federal R&D funding.
The top 10 more mature companies earned combined revenues of $12.4 million. They also reported investment dollars and federal R&D grants totaling an additional $12.3 million. Several of the companies are now scheduled for "graduation," due to their very positive financial results and that they reached other key milestones. These companies will be announced in future issues. |
PSBA
